Nateglinide is an N-acyl-D-phenylalanine derivative that functions as an orally administered, rapidly absorbed, short-acting insulinotropic agent. It is used as a hypoglycemic agent and an inhibitor of dipeptidyl-peptidase IV, primarily in the manufacturing of pharmaceutical products for type 2 diabetes mellitus.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 105816-06-6
Nateglinide
pharmaceutical raw material
N-[4-(Propan-2-yl)cyclohexane-1-carbonyl]-D-phenylalanyl-D-phenylalanine
research compound
Nateglinide Methyl Ester
pharmaceutical intermediate
Tropisetron hydrochloride
pharmaceutical raw material
Doxycycline hydrochloride
pharmaceutical raw material
Clinafloxacin
pharmaceutical raw material
Clodronic acid
pharmaceutical raw material
Ent-Nateglinide
pharmaceutical raw material
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
OELFLUMRDSZNSF-OFLPRAFFSA-N
CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O